Relmada Therapeutics appoints new chief financial officer
May 17, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing chief financial officer, relmada
Michael D. Becker has been appointed the new chief financial officer at Relmada Therapeutics. Becker joined the company in 2014 …
Biogen signs $2 billion partnership deal with UPenn for gene therapies
May 17, 2016Research and Development, Sales and Marketing Biogen, collaboration, deal, gene therapy, research
Biogen (Nasdaq: BIIB) said it has signed a deal worth up to $2 billion with the University of Pennsylvania to …
Actelion granted EU approval for hypertension treatment
May 17, 2016Manufacturing and Production, Sales and Marketing Actelion, Uptravi, eu approval, hypertension
Actelion Pharmaceuticals has received marketing authorisation from the European Commission for Uptravi (selexipag) for the long-term treatment of patients with …
Allergan’s chronic eye disease treatment meets endpoints in pivotal trials
May 17, 2016Manufacturing and Production, Sales and Marketing Allergan, FDA, chronic eye disease
Allergan has announced positive top line results from two pivotal late-stage trials for the first and only neurostimulation device for …
AstraZeneca says its respiratory biologic meets primary endpoint in Phase III trial
May 17, 2016Manufacturing and Production, Research and Development AstraZeneca, asthma drug, benralizumab, drug trial
UK-based AstraZeneca (LSE: AZN) on Tuesday said late stage trials for its biologic asthma drug met the primary endpoint. Chief …
Valeant announces expanded discounts for Nitropress and Isuprel
May 17, 2016Manufacturing and Production, Sales and Marketing Isuprel, Nitropress, Valeant, discounts
Valeant Pharmaceuticals (NYSE: VRX) has stepped up its public relations campaign with an announcement of expanded discounts for Nitropress (nitroprusside) …
Aduro’s pancreatic cancer immunotherapy fails Phase II trials; shares plunge
May 17, 2016Manufacturing and Production, Research and Development, Sales and Marketing Aduro Biotech, Pancreatic cancer, Stock, drug trial, markets
Shares in Aduro Biotech (Nasdaq: ADRO) dropped to closed down over 16% after the company said mid-stage trials of its …
Pfizer to acquire Anacor in $5.2 billion deal
May 16, 2016Manufacturing and Production, Sales and Marketing 5.2 billion, FDA, Pfizer, acquisition, anacor, crisaborole, merger
Pfizer (NYSE: PFE) has acquired Anacor Pharmaceuticals (NASDAQ: ANAC) in a deal worth around $5.2 billion, or $99.25 per share. …
Mylan to buy Renaissance’s dermatology business for up to $1 billion
May 16, 2016Research and Development, Sales and Marketing Mylan, generics, merger and acquisition
Generics maker Mylan (Nasdaq: MYL) has agreed to buy skincare products from Renaissance Acquisition Holdings for up to $1 billion. …
Sanofi to replace entire Medivation board to drive sale, according to reports
May 16, 2016Manufacturing and Production, Research and Development, Sales and Marketing Medivation, Sanofi, replace board, takeover
Reports have emerged that Sanofi is looking to step up its efforts to take over oncology firm, Medivation, as it …
Weekly Movers: Teva, Midatech, Allergan…
May 16, 2016Research and Development, Sales and Marketing Allergan, Ariad Pharmaceuticals, Lundbeck, Midatech Pharma, Stock, Teva Pharmaceutical, markets
We have hit the tail end of the earnings season and the near last batch of movers follow result pronouncements …
Novartis says trials show its COPD drug more effective versus GSK’s Seretide
May 16, 2016Research and Development, Sales and Marketing GSK, Novartis, drug trial, research
Swiss drug firm Novartis (VTX: NOVN) said its asthma drug showed efficacy over GlaxoSmithKline’s (LSE: GSK) medicine in a comparison …
Eisai granted additional indication for Lenvima in renal cell carcinoma
May 16, 2016Sales and Marketing Eisai, additional indication, renal cell carcinoma
Eisai has announced that it has received approval from the US Food and Drug Administration (FDA) for an additional indication …
Pfizer presents positive results in meningococcal disease late-stage trials
May 13, 2016Research and Development Pfizer, Vaccine, late stage trials, meningococcal disease
Pfizer (NYSE: PFE) has announced results from two pivotal late-stage trials demonstrating the immunogenicity of Trumenba against invasive meningococcal B …
Clinical Trials Equipment Supplier Woodley Equipment Exhibiting at Outsourcing in Clinical Trials East Coast 2016
May 13, 2016Woodley Equipment Company Limited is exhibiting at Outsourcing in Clinical Trials East Coast 2016. The event is taking place on …
Woodley Equipment Company Limited UK Office
May 13, 2016Woodley Equipment Company Limited UK Office
US pass new laws to combat opioid epidemic
May 13, 2016Medical Communications, Sales and Marketing US, epidemic, fight back, new laws, opioids, reverse
The US has passed new laws that will seek to combat the current epidemic of opioids across the country. The …
EU approves Idelvion for haemophilia B treatment
May 13, 2016Medical Communications, Research and Development CSL, EU, Idelvion, approval, haemophilia B
The European Commission has approved Idelvion, coagulation Factor IX (recombinant) for the treatment and prophylaxis of bleeding in patients with …
Sanofi Files Hart-Scott-Rodino notification for Medivation acquisition
May 13, 2016Medical Communications, Sales and Marketing M&A, MA, Medivation, Sanofi, deal
French drugmaker Sanofi (Euronext: SAN) on Friday said it has filed a premerger notification with the US Department of Justice Antitrust …
Sobi, Biogen’s haemophilia B therapy gets European approval
May 13, 2016Medical Communications, Research and Development, Sales and Marketing Biogen, haemophilia B, orphan designation, regulation, sobi
Sobi (STO: SOBI) and Biogen (Nasdaq: BIIB) on Friday said the European Commission has approved their drug to treat haemophilia B. The …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
